Mechanism of action of Xipayimaizibizi oral liquid on outlet obstruction-induced overactive bladder: An integrated study

Mechanism of action of Xipayimaizibizi oral liquid on outlet obstruction-induced overactive bladder: An integrated study

Objective: To observe the effect of Xipayimaizibizi oral liquid (XP) in an overactive bladder (OAB) experimental rat model and to explore its pharmacological mechanisms. Methods: Network pharmacology was used to explore the potential mechanisms of action of XP. The rats underwent bladder outlet obst...

Full description

Saved in:

Bibliographic Details
Main Authors:	Menglu Wang, Yang Yang, Yuhang Du, Jiamei Xie, Yige Zhao, Yongcheng An, Ziyi Shan, Shenyujun Wang, Meng Hao, Baosheng Zhao
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Journal of Traditional Chinese Medical Sciences
Subjects:	Xipayimaizibizi oral liquid Overactive bladder Partial bladder outlet obstruction Muscarinic receptor Cholinergic synapse Calcium signaling pathway
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095754824000978
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Guidelines for the Treatment of Urinary Incontineence and Overactive Bladder
by: C.F. Heyns, et al.
Published: (2002-03-01)

The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation
by: Kürşat Küçüker, et al.
Published: (2025-03-01)

Review of simultaneous treatment with intradetrusor onabotulinumtoxinA injections during transurethral prostate surgery for men with bladder outlet obstruction and overactive bladder
by: Chun-Kai Hsu, et al.
Published: (2025-01-01)

Prevalence, impact on quality of life, and predictive factors of coexistence of overactive bladder and underactive bladder in men
by: Noritoshi Sekido, et al.
Published: (2025-07-01)

Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study
by: Jae Hun Shim, et al.
Published: (2021-04-01)

Does Anticholinergic Burden Influence Therapeutic Success in Patients with Treatment-naïve Overactive Bladder?
by: João Oliveira, et al.
Published: (2025-09-01)

MANAGEMENT OF PATIENTS WITH PARKINSON’S DISEASE AND AN OVERACTIVE BLADDER
by: E. S. Korshunova, et al.
Published: (2018-01-01)

Effectiveness of Solifenacin versus Mirabegron in the Treatment of Overactive Bladder: A Prospective Cohort Study
by: Shyamali Dutta, et al.
Published: (2025-07-01)

Overactive Bladder: Where We Are and Where We Are Going
by: Charan S. Mohan, et al.
Published: (2021-09-01)

Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs
by: Nazish Sarfraz, et al.
Published: (2023-12-01)

Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder
by: Byeong Jo Jeon, et al.
Published: (2024-12-01)

Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females
by: Claudia Covarrubias, et al.
Published: (2025-06-01)

Association of Age With Lower Urinary Tract Function in Adult Men Presenting for Urodynamics: A Database Analysis
by: Sanjay Sinha, et al.
Published: (2021-09-01)

The Role of Bladder Trabeculation as a Diagnostic Indicator in the Assessment of Bladder Outlet Obstruction
by: Chengalvarayan G, et al.
Published: (2025-06-01)

Abnormal Cerebral Perfusion and Functional Connectivity in Women with Overactive Bladder
by: Shichun Chen, et al.
Published: (2025-06-01)

Association between overactive bladder and female sexual frequency: a cross-sectional analysis of the National Health and nutrition examination survey data
by: Bo Zhang, et al.
Published: (2025-02-01)

Transvertebral magnetic neuromodulation for the treatment of overactive bladder: 6 months follow-up
by: G V. Kovalev, et al.
Published: (2020-12-01)

Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
by: I Gede Yogi Prema Ananda, et al.
Published: (2025-01-01)

Relationship between urodynamic patterns and lower urinary tract symptoms in Chinese women with a non-neurogenic bladder
by: Linhui Wang, et al.
Published: (2016-01-01)

Mirabegron in the Management of Overactive Bladder Syndrome in Ghazi Al-Hariri Hospital
by: Hiba H. Razaq, et al.
Published: (2025-04-01)

Compatibility of the urodynamic findings and mixed urinary incontinence symptoms
by: Fatemeh Mallah, et al.
Published: (2024-05-01)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01)

Acupuncture combined with mirabegron is efficacious for the treatment of overactive bladder: a prospective randomized controlled trial
by: Deng Xiaolin, et al.
Published: (2025-07-01)

The Management of Children and Adolescents with Overactive Bladder Refractory to Treatment with Parasacral Transcutaneous Electrical Nerve Stimulation
by: Carlos Eduardo Rocha Macedo, et al.
Published: (2025-01-01)

Risk factors, urodynamic characteristics, and distress associated with nocturnal enuresis in overactive bladder -wet women
by: Kuan Chong Ng, et al.
Published: (2025-01-01)

Short-term effectiveness and safety of sacral nerve modulation in the treatment of bladder-and-bowel dysfunction: a preliminary exploration of 16 cases
by: Qian Ruijun, et al.
Published: (2023-12-01)

The role of Kegel exercises in reducing involuntary loss of urine in Overactive Bladder and Mixed Urinary Inconti-nence
by: Lucian Șerbanescu, et al.
Published: (2025-01-01)

New insights into the association between arthritis and overactive bladder in NHANES 2005–2020
by: Yifan Sun, et al.
Published: (2025-02-01)

Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction
by: Wan-Ru Yu, et al.
Published: (2024-01-01)

Association between novel anthropometric indices and overactive bladder: a population-based study
by: Heng Liu, et al.
Published: (2025-01-01)

Secondary overactive bladder syndrome with restless legs syndrome following cerebral infarction: report of 2 cases
by: Ying Cui, et al.
Published: (2025-03-01)

Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation
by: Rajabalaya Rajan, et al.
Published: (2017-09-01)

Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
by: Rachel Stading, et al.
Published: (2024-12-01)

Correlation between excessive sugar intake and overactive bladder in children
by: Xu Cui, et al.
Published: (2025-05-01)

The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model
by: Jan Wróbel, et al.
Published: (2025-01-01)

THE EFFECT OF INTRAVESICAL ONABOTULINUM TOXIN A TREATMENT ON QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER
by: Tuğçe Arslanoğlu, et al.
Published: (2023-03-01)

Masks of Chronic Prostatitis: Overactive bladder and Myofascial Syndrome. Case study
by: E. V. Kulchavenya, et al.
Published: (2019-09-01)

The effectiveness of intravesical oxybutynin in the management of overactive bladder: a clinical study
by: Shoeb Alahmad, et al.
Published: (2024-12-01)

Relationship between metabolic syndrome and overactive bladder: insights from the NHANES and Mendelian randomization study
by: Zhihao Liu, et al.
Published: (2025-08-01)

How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies
by: Hann-Chorng Kuo
Published: (2022-01-01)